LIVE - Dallas PCI: Coronary imaging and physiology

Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.

Dr. Dib is board certified in cardiovascular disease and interventional cardiology. In addition, he has completed extensive training in nuclear cardiology and is certified by the Certification Board of Nuclear Cardiology. His clinical interests include coronary artery disease and interventions, peripheral artery disease and interventions, structural heart disease, venous disease, ablation, thrombectomy, pacemaker implantation and interrogation. After finishing his internship and residency training at Mayo Clinic, Dr. Dib went on to complete a fellowship in Cardiovascular Disease at the University of Oklahoma Health Sciences Center in Oklahoma City and a fellowship in Interventional Cardiology at the University of Texas Health Science Center in Houston. He is also a fellow of the American College of Cardiology and the Society of Cardiac Angiography and Interventions. Dr. Dib is on the medical staff at The Heart Hospital Baylor Plano and Baylor Scott & White Medical Center – McKinney. He is currently welcoming new patients.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >600 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 74) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Dr Justin Davies is a honorary 
interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to
work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents,
he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).

Dr. Karim Al-Azizi is an Interventional Cardiologist and Structural Heart Disease specialist at Baylor Scott & White Health - The Heart Hospital in Plano, TX. He is the Medical Director of the Cardiac Catheterization Laboratories and the Associate Program Director of the Cardiovascular disease fellowship and a clinical assistant professor at the Texas A and M College of Medicine. His clinical and research interests include complex coronary interventions, ultra-low contrast, physiology and imaging-guided PCI, and transcatheter interventions for valvular heart disease. He speaks at national and international conferences on these subjects and serves as a principal investigator on multiple clinical trials in the field of structural and coronary interventions.

Sameh Sayfo, MD, RPVI is an interventional cardiologist with Legacy Heart Center. He specializes in the management of cardiac diseases including atrial fibrillation, coronary artery disease, peripheral arterial and venous disease, and heart failure. His areas of expertise include complex coronary and peripheral artery interventions, atrial septal defect and patent foramen ovale closures, aortic valve treatment including valvuloplasty and transcather aortic valve replacement (TAVR), as well as endovascular aortic repair (EVAR) and carotid stenting. Dr. Sayfo is certified by the National Board of Echocardiography and he is a Registered Physician in Vascular Interpretation (RPVI) certified by the American Registry for Diagnostic Medical Sonography. He is also specially trained in venous ablation, treating venous diseases including varicose and spider veins using both endovenous laser treatment (EVLT) and radiofrequency ablation. In addition, he is active in clinical research and has a special interest in interventional cardiology studies. Dr. Sayfo is on the medical staff at The Heart Hospital Baylor Plano, Baylor Regional Medical Center at Plano, and Baylor Medical Center at McKinney. He is currently welcoming new patients.

Srini Potluri, MD, FACC FSCAI is chairman of cardiology at Baylor Scott and White The Heart Hospital Plano, medical director of their cardiac catheterization laboratory and associate professor at Texas A&M. He also serves as the program director of interventional cardiology fellowship. He is on the board of Baylor Scott and White Cardiovascular Governance Council assisting in improving system wide cardiovascular quality and operations. He joined Baylor Scott and White Legacy Heart Center from the Ochsner Clinic Foundation in New Orleans, Louisiana where he completed fellowships in cardiology and interventional cardiology. During his training he served as chief resident and chief interventional fellow and also received several awards in research and clinical excellence. His clinical interests are complex coronary interventions, chronic total occlusion intervention, transcatheter heart valve replacement, septal defect closures, left atrial appendage closures. In his busy practice he serves patients from North Texas and surrounding areas. He was named the best doctor in Dallas for several years. He is well published in the field of coronary and structural intervention and principal investigator in several national and global clinical research trials. He also serves on several industry advisory boards and actively participates and speaks at major national cardiovascular meetings. He lives in Frisco, TX with his wife and three daughters.

Dr Sukhjinder Nijjer is a Consultant Cardiologist and Honorary Senior Clinical Lecturer at Imperial College London. He is the President of Cardiology at the Royal Society of Medicine and is the Communication Lead for the British Cardiovascular Intervention Society. He works at the Hammersmith Hospital as an Interventional Cardiologist and is an expert in Coronary Physiology. His PhD research focused on the development of instantaneous wave-free ratio (iFR) pullback and co-registration. He has published over 100 original academic papers and has involved in the DEFINE-FLAIR, SYNTAX-II and ORBITA-1 and ORBITA-2 research studies.

Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.